Denver Investment Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
$465K Sell
6,170
-382
-6% -$30.4K 0.02% 328
2017
Q4
$469K Hold
6,552
0.02% 324
2017
Q3
$531K Sell
6,552
-1,020
-13% -$78K 0.03% 311
2017
Q2
$536K Buy
7,572
+1,449
+24% +$96.4K 0.02% 311
2017
Q1
$416K Sell
6,123
-325
-5% -$22.9K 0.02% 361
2016
Q4
$462K Buy
+6,448
New +$479K 0.02% 355
2016
Q3
Sell
-25,963
Closed -$2.17M 458
2016
Q2
$2.17M Sell
25,963
-1,573
-6% -$140K 0.1% 195
2016
Q1
$2.53M Sell
27,536
-658
-2% -$59.3K 0.11% 185
2015
Q4
$2.85M Sell
28,194
-15,222
-35% -$1.58M 0.13% 178
2015
Q3
$4.26M Sell
43,416
-3,192
-7% -$355K 0.19% 140
2015
Q2
$5.46M Sell
46,608
-10,477
-18% -$1.14M 0.2% 128
2015
Q1
$5.6M Sell
57,085
-22,437
-28% -$2.28M 0.18% 138
2014
Q4
$7.5M Buy
79,522
+7,406
+10% +$766K 0.24% 120
2014
Q3
$7.68M Sell
72,116
-3,768
-5% -$369K 0.25% 112
2014
Q2
$6.29M Sell
75,884
-3,110
-4% -$242K 0.19% 135
2014
Q1
$5.6M Sell
78,994
-5,524
-7% -$433K 0.16% 172
2013
Q4
$6.35K Sell
84,518
-3,650
-4% -$254K 0.18% 169
2013
Q3
$5.54M Sell
88,168
-946
-1% -$56.5K 0.12% 214
2013
Q2
$4.58M Buy
+89,114
New +$4.64M 0.11% 219

Other funds holding GILD

Denver Investment Advisors's GILD Position: Q1 2018 in Review

Denver Investment Advisors reduced its Gilead Sciences (GILD) stake by 5.8% in Q1 2018, selling an estimated $30.4K and leaving 6,170 shares worth $465K. The position accounts for 0.02% of the portfolio, ranked #328.

Denver Investment Advisors first reported a position in GILD in Q2 2013 and has held it in 19 quarters since. The position peaked at $7.68M in Q3 2014. 1,564 funds tracked by Wall St. Rank hold GILD as of Q1 2018.

  • Denver Investment Advisors held 6,170 shares of Gilead Sciences worth $465K as of Q1 2018.
  • Denver Investment Advisors sold 382 Gilead Sciences shares in Q1 2018, an estimated $30.4K.
  • Gilead Sciences made up 0.02% of Denver Investment Advisors's portfolio in Q1 2018, its #328 holding.
  • Denver Investment Advisors first reported a position in Gilead Sciences in Q2 2013 and has held it in 19 quarters since.
  • Denver Investment Advisors's Gilead Sciences position peaked at $7.68M in Q3 2014.
  • 1,564 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2018.

Based on Denver Investment Advisors's 13F filing for Q1 2018, filed 10 May 2018.